CN105273209A - 一种改性壳聚糖与聚(2-丙烯酰胺-2-甲基丙磺酸)复合微球的制备 - Google Patents
一种改性壳聚糖与聚(2-丙烯酰胺-2-甲基丙磺酸)复合微球的制备 Download PDFInfo
- Publication number
- CN105273209A CN105273209A CN201410250398.4A CN201410250398A CN105273209A CN 105273209 A CN105273209 A CN 105273209A CN 201410250398 A CN201410250398 A CN 201410250398A CN 105273209 A CN105273209 A CN 105273209A
- Authority
- CN
- China
- Prior art keywords
- microballoon
- pamps
- acrylamide
- chitosan
- complex microsphere
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001661 Chitosan Polymers 0.000 title claims abstract description 68
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000002131 composite material Substances 0.000 title abstract description 9
- -1 poly(2-acrylamide-2-methylpropanesulfonic acid) Polymers 0.000 title abstract 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract 2
- 239000004005 microsphere Substances 0.000 claims description 36
- 230000004048 modification Effects 0.000 claims description 18
- 238000012986 modification Methods 0.000 claims description 18
- 229920000642 polymer Polymers 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- RINCXYDBBGOEEQ-UHFFFAOYSA-N succinic anhydride Chemical compound O=C1CCC(=O)O1 RINCXYDBBGOEEQ-UHFFFAOYSA-N 0.000 claims description 5
- 125000000542 sulfonic acid group Chemical group 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 3
- 239000005662 Paraffin oil Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- 238000010907 mechanical stirring Methods 0.000 claims description 3
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 239000011837 N,N-methylenebisacrylamide Substances 0.000 claims description 2
- 239000003999 initiator Substances 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 238000006116 polymerization reaction Methods 0.000 claims description 2
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 claims description 2
- IRLPACMLTUPBCL-KQYNXXCUSA-N 5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O IRLPACMLTUPBCL-KQYNXXCUSA-N 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- 239000004160 Ammonium persulphate Substances 0.000 claims 1
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 claims 1
- 235000019395 ammonium persulphate Nutrition 0.000 claims 1
- 230000015556 catabolic process Effects 0.000 claims 1
- 239000008367 deionised water Substances 0.000 claims 1
- 229910021641 deionized water Inorganic materials 0.000 claims 1
- 238000004945 emulsification Methods 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 235000011167 hydrochloric acid Nutrition 0.000 claims 1
- 239000000178 monomer Substances 0.000 claims 1
- 239000003505 polymerization initiator Substances 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 28
- 229940079593 drug Drugs 0.000 abstract description 16
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 abstract description 10
- 238000011068 loading method Methods 0.000 abstract description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract description 5
- 229960004679 doxorubicin Drugs 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 3
- 125000003277 amino group Chemical group 0.000 abstract description 2
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 abstract 1
- 239000003431 cross linking reagent Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 229940014800 succinic anhydride Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 8
- 229960000641 zorubicin Drugs 0.000 description 7
- FBTUMDXHSRTGRV-ALTNURHMSA-N zorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(\C)=N\NC(=O)C=1C=CC=CC=1)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 FBTUMDXHSRTGRV-ALTNURHMSA-N 0.000 description 7
- 239000011806 microball Substances 0.000 description 6
- 230000002522 swelling effect Effects 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 208000005189 Embolism Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- MWWSFMDVAYGXBV-RUELKSSGSA-N Doxorubicin hydrochloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-RUELKSSGSA-N 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229960002918 doxorubicin hydrochloride Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000004159 Potassium persulphate Substances 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000019394 potassium persulphate Nutrition 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical group OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410250398.4A CN105273209B (zh) | 2014-06-09 | 2014-06-09 | 一种改性壳聚糖与聚(2-丙烯酰胺-2-甲基丙磺酸)复合微球的制备 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410250398.4A CN105273209B (zh) | 2014-06-09 | 2014-06-09 | 一种改性壳聚糖与聚(2-丙烯酰胺-2-甲基丙磺酸)复合微球的制备 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105273209A true CN105273209A (zh) | 2016-01-27 |
CN105273209B CN105273209B (zh) | 2018-05-22 |
Family
ID=55143091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410250398.4A Expired - Fee Related CN105273209B (zh) | 2014-06-09 | 2014-06-09 | 一种改性壳聚糖与聚(2-丙烯酰胺-2-甲基丙磺酸)复合微球的制备 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105273209B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106110334A (zh) * | 2016-08-08 | 2016-11-16 | 江南大学 | 一种表面功能化可载药洗脱微球的制备方法 |
CN110201215A (zh) * | 2019-06-11 | 2019-09-06 | 科睿驰(深圳)医疗科技发展有限公司 | 一种梯度交联高弹性栓塞微球及其制备工艺 |
CN112316199A (zh) * | 2020-11-16 | 2021-02-05 | 江南大学 | 一种改性羧甲基壳聚糖微球及其制备方法和应用 |
CN114478927A (zh) * | 2022-01-26 | 2022-05-13 | 科睿驰(深圳)医疗科技发展有限公司 | 一种栓塞微球及梯度交联制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101240077A (zh) * | 2007-12-19 | 2008-08-13 | 天津大学 | 壳聚糖与丙烯酸-2-丙烯酰胺-2-甲基丙磺酸共聚物共混膜及制备方法与应用 |
CN101602876A (zh) * | 2009-06-23 | 2009-12-16 | 南京大学 | 高力学强度和电化学活性的多重网络复合水凝胶材料及其制法 |
CN103113700A (zh) * | 2013-01-18 | 2013-05-22 | 盐城工学院 | 互穿网络结构水凝胶创面敷料及其制备方法 |
-
2014
- 2014-06-09 CN CN201410250398.4A patent/CN105273209B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101240077A (zh) * | 2007-12-19 | 2008-08-13 | 天津大学 | 壳聚糖与丙烯酸-2-丙烯酰胺-2-甲基丙磺酸共聚物共混膜及制备方法与应用 |
CN101602876A (zh) * | 2009-06-23 | 2009-12-16 | 南京大学 | 高力学强度和电化学活性的多重网络复合水凝胶材料及其制法 |
CN103113700A (zh) * | 2013-01-18 | 2013-05-22 | 盐城工学院 | 互穿网络结构水凝胶创面敷料及其制备方法 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106110334A (zh) * | 2016-08-08 | 2016-11-16 | 江南大学 | 一种表面功能化可载药洗脱微球的制备方法 |
CN106110334B (zh) * | 2016-08-08 | 2019-11-15 | 江南大学 | 一种表面功能化可载药洗脱微球的制备方法 |
CN110201215A (zh) * | 2019-06-11 | 2019-09-06 | 科睿驰(深圳)医疗科技发展有限公司 | 一种梯度交联高弹性栓塞微球及其制备工艺 |
CN110201215B (zh) * | 2019-06-11 | 2021-07-30 | 科睿驰(深圳)医疗科技发展有限公司 | 一种梯度交联高弹性栓塞微球及其制备工艺 |
CN112316199A (zh) * | 2020-11-16 | 2021-02-05 | 江南大学 | 一种改性羧甲基壳聚糖微球及其制备方法和应用 |
CN114478927A (zh) * | 2022-01-26 | 2022-05-13 | 科睿驰(深圳)医疗科技发展有限公司 | 一种栓塞微球及梯度交联制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105273209B (zh) | 2018-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107550921B (zh) | 一种纳米颗粒-高分子可注射复合水凝胶双载药体系及其制备方法 | |
CN105250214B (zh) | 一种氨基酸修饰的聚合物纳米水凝胶药物载体的制备方法 | |
Mohamadhoseini et al. | Supramolecular self-healing materials via host-guest strategy between cyclodextrin and specific types of guest molecules | |
Pandey et al. | Rapid synthesis of superabsorbent smart‐swelling bacterial cellulose/acrylamide‐based hydrogels for drug delivery | |
Bardajee et al. | Multi-stimuli responsive nanogel/hydrogel nanocomposites based on κ-carrageenan for prolonged release of levodopa as model drug | |
CN105273209A (zh) | 一种改性壳聚糖与聚(2-丙烯酰胺-2-甲基丙磺酸)复合微球的制备 | |
CN111363169A (zh) | 一种pH敏感型水凝胶的制备方法 | |
Chen et al. | Effective drug carrier based on polyethylenimine-functionalized bacterial cellulose with controllable release properties | |
Işıklan et al. | Synthesis and characterization of pH-and temperature-sensitive materials based on alginate and poly (N-isopropylacrylamide/acrylic acid) for drug delivery | |
Hu et al. | Smart pH-responsive polymeric micelles for programmed oral delivery of insulin | |
Sheikh et al. | A study on the swelling behavior of poly (acrylic acid) hydrogels obtained by electron beam crosslinking | |
Dong et al. | Thermoresponsive hyperbranched copolymer with multi acrylate functionality for in situ cross-linkable hyaluronic acid composite semi-IPN hydrogel | |
CN103881014B (zh) | 一种高回弹快速双响应poss杂化水凝胶的制备方法 | |
Karnoosh-Yamchi et al. | Preparation of pH sensitive insulin-loaded nano hydrogels and evaluation of insulin releasing in different pH conditions | |
CN110227069B (zh) | 一种pH响应型单宁酸/壳聚糖纳米胶囊及其制备方法 | |
CN106668870B (zh) | 一种载药聚吡咯/海藻酸钠凝胶的制备方法 | |
CN107899066A (zh) | 阳离子多羟基聚合物栓塞微球及其制备方法 | |
CN107641181A (zh) | 一种具有光和pH双重响应性的两嵌段共聚物及其制备方法 | |
CN106063782B (zh) | 一种还原敏感载药纳米水凝胶微球及其制备方法 | |
CN104892949A (zh) | 一种谷胱甘肽/pH双重刺激响应离子交联型聚合物纳米水凝胶及其制备方法和应用 | |
Zhang et al. | A facile, efficient and “green” route to pH-responsive crosslinked poly (methacrylic acid) nanoparticles | |
Taleb | Radiation synthesis of polyampholytic and reversible pH-responsive hydrogel and its application as drug delivery system | |
Shang et al. | Preliminary studies on pH-sensitive hydrogels and in vitro release profiles of two model drugs | |
US9999599B2 (en) | Polymer-polymer composite nanoassemblies and applications thereof | |
CN110818864B (zh) | 一种提升抗菌功效的高分子抗菌剂的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180223 Address after: 100086 Beijing city Haidian District North Sanhuan Road 43, Tsing Wun contemporary building 12A11 Applicant after: BEIJING ZHITAO SCIENCE & TECHNOLOGY CO., LTD. Address before: School of chemical engineering Jiangnan University No. 1800 214122 Jiangsu city of Wuxi Province Li Lake Avenue Applicant before: Jiangnan University |
|
TA01 | Transfer of patent application right | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Xiaobin Inventor after: Zhu Yongxing Inventor before: Ni Caihua Inventor before: Zhang Meng Inventor before: Zhang Liping Inventor before: Shi Gang |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180426 Address after: 211122 2 dry road, Jiangning District, Nanjing, Jiangsu (Jiangning Gao Xinyuan) Applicant after: Nanjing Shunchang medical science and Technology Co Ltd Address before: 100086 Qingyun contemporary building, 43 North Sanhuan Road, Haidian District, Beijing, 12A11 Applicant before: BEIJING ZHITAO SCIENCE & TECHNOLOGY CO., LTD. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180522 Termination date: 20190609 |
|
CF01 | Termination of patent right due to non-payment of annual fee |